Spa therapy for psoriasis quality of life
Part of Skin clinical trials.
This trial tests if an 18-day spa treatment designed for skin conditions can improve quality of life in people with psoriasis. You must have moderate-to-severe psoriasis (DLQI score over 10) and stable treatment for the last 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have psoriasis and your treatment has been stable for the last 6 months
- Your psoriasis significantly affects your daily life (score over 10 on a standard questionnaire)
- You are available for an 18-day spa stay and 9 months of follow-up
- You have health insurance or similar coverage
- If you can become pregnant, you use effective birth control
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what’s happening inside the body in people with plaque psoriasis who start certain biologic medicines that target the IL-23/IL-17 immune pathway. It may help explain why these treatments work and what body changes are linked to response.
This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.
This trial tests if adding a gluten-free, low-histamine anti-inflammatory diet, and in some cases physical therapy, helps children with mild-to-moderate plaque psoriasis. It aims to see if these lifestyle changes can improve skin symptoms when combined with usual treatment.
This trial tests whether using a special light to see psoriasis tissue more clearly helps doctors remove it more precisely with a laser. It may lead to better treatment results for people with psoriasis.
This trial tests an oral medication called TQH3906 for people with moderate to severe plaque psoriasis. It aims to see if the drug can improve skin symptoms and is for adults who have not had enough success with other treatments.
This trial tests a new study drug called HSK44459 for people with moderate to severe plaque psoriasis. The hope is that the drug can reduce psoriasis symptoms and improve quality of life. Participation involves receiving the study drug and being monitored for safety and effectiveness.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.